Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
40S ribosomal protein S12 is a structural component of the small 40S subunit of eukaryotic cytoplasmic ribosomes, encoded by the RPS12 gene in humans[1][3]. It belongs to the S12E family of ribosomal proteins and is essential for accurate mRNA decoding during translation. The human form is located in the cytoplasm as part of the machinery that catalyzes cellular protein synthesis. Increased expression has been observed in certain cancers, such as colorectal cancer[1]. While not a direct therapeutic target itself, its bacterial and mitochondrial homologs are targeted by aminoglycoside antibiotics due to their role in translational fidelity; these drugs bind near or at this site on prokaryotic/mitochondrial small subunits to disrupt normal function[4][5].
Inhibition of translation by binding to the small ribosomal subunit and interfering with decoding fidelity or tRNA selection[4][5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 40S ribosomal protein S12 (RPS12).